A.R.T. Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

A.R.T. Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-108,100	Closed	-$1.19M	–	1931
2017 Q1	$1.19M	Buy	108,100 +90,900	+528%	+$1.06M	0.05%	495
2016 Q4	$233K	Buy	+17,200	New	+$240K	0.01%	1017
2015 Q4	–	Sell	-22,776	Closed	-$452K	–	1877
2015 Q3	$452K	Sell	22,776 -16,262	-42%	-$373K	0.02%	915
2015 Q2	$641K	Sell	39,038 -24,393	-38%	-$423K	0.02%	901
2015 Q1	$986K	Buy	63,431 +19,109	+43%	+$296K	0.03%	661
2014 Q4	$632K	Buy	+44,322	New	+$468K	0.02%	832
2014 Q3	–	Sell	-14,750	Closed	-$101K	–	1666
2014 Q2	$101K	Sell	14,750 -25,777	-64%	-$182K	0.01%	1214
2014 Q1	$289K	Buy	+40,527	New	+$347K	0.02%	994
2013 Q4	–	Sell	-18,164	Closed	-$113K	–	1673
2013 Q3	$113K	Sell	18,164 -53,527	-75%	-$334K	0.01%	1208
2013 Q2	$471K	Buy	+71,691	New	+$569K	0.02%	902

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

A.R.T. Advisors's SCMP Position: Q2 2017 in Review

A.R.T. Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 108,100 shares — an estimated $1.19M sold.

A.R.T. Advisors first reported a position in SCMP in Q2 2013 and held it in 10 quarters. The position peaked at $1.19M in Q1 2017. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

A.R.T. Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
A.R.T. Advisors sold 108,100 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $1.19M.
A.R.T. Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
A.R.T. Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $1.19M in Q1 2017.
167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.